Scenario | Description |
---|---|
Status quo | No changes to the current situation |
1: 100% testing rate | Full compliance with national testing guidelines, which includes testing of all febrile or suspected cases with RDTs (i.e., phase-out of microscopy) |
2: Increase testing rate by 10% | Increase overall testing rate by 10% (from 47 to 52%) and the RDT testing rate by 10% (from 69 baseline to 76%) across all types of providers* |
3: 100% treatment rate | Full compliance with national treatment guidelines, which includes 100% treatment of all test-positive cases and treatment of uncomplicated cases with AL and severe cases with IV/IM artesunate |
4: Increase treatment rate by 10% | Increase overall treatment rate by 10% (from 99 to 100%) and increase ACT treatment rate by 10% (from 84 to 92%)* |
5: Scenarios 1 and 3 | Combination of Scenarios 1 and 3; full compliance with testing and treatment guidelines, 100% testing with RDTs, and 100% treatment with AL for uncomplicated cases and IV/IM AS for severe cases |
6: Scenarios 2 and 4 | Combination of Scenarios 2 and 4; increase in overall testing and treatment rates by 10%, RDT testing rate by 10%, and ACT treatment rate by 10% |